サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1594991

店頭（OTC）検査の世界市場

Over The Counter (OTC) Testing

出版日
ページ情報
英文 89 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.06円
店頭（OTC）検査の世界市場
出版日: 2024年11月22日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 89 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

店頭（OTC）検査の世界市場は2030年までに436億米ドルに達する見込み

2023年に233億米ドルと推定された店頭（OTC）検査の世界市場は、2030年には436億米ドルに達し、分析期間2023-2030年のCAGRは9.3%で成長すると予測されます。本レポートで分析したセグメントの1つであるグルコースモニタリング検査は、CAGR 8.2％を記録し、分析期間終了までに117億米ドルに達すると予測されます。妊娠・不妊検査分野の成長率は、分析期間中CAGR 9.5％と推定されます。

米国市場は63億米ドル、中国はCAGR 8.8％で成長すると予測

米国の店頭（OTC）検査市場は2023年に63億米ドルと推定されます。世界第2位の経済大国である中国は、2023年から2030年の分析期間においてCAGR 8.8%で推移し、2030年には68億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ7.8%と7.8%と予測されています。欧州では、ドイツがCAGR約6.6%で成長すると予測されています。

世界の一般用医薬品（OTC）検査市場- 主要動向と促進要因のまとめ

アクセス可能なヘルスケアに店頭検査が不可欠な理由とは？

市販（OTC）検査は、自宅で個人的に便利に実施できる健康検査への直接アクセスを個人に提供することで、ヘルスケアに革命をもたらしました。OTC検査では、血糖値やコレステロール値から妊娠、不妊、感染症に至るまで、さまざまな健康指標を、医師の診察や処方箋を必要とせずにモニターすることができます。ヘルスケアがより患者中心で利用しやすい医療へとシフトする中、OTC検査は、積極的な健康管理を求める個人にとって不可欠なツールとなっています。自分の都合に合わせて検査できるOTC検査は、時間や費用、アクセスしやすさの問題など、従来の検査室での検査に伴う障壁を取り除き、ヘルスケアをより包括的なものにしています。

OTC検査は、継続的なモニタリングが効果的なケアに不可欠な糖尿病のような慢性疾患の管理に、特に大きな影響を及ぼしています。最も広く利用されているOTC検査のひとつである血糖値測定器は、糖尿病患者に毎日の血糖値を追跡させ、投薬管理や生活習慣の調整に役立っています。同様に、家庭でできるコレステロール検査は、心血管疾患のリスクを持つ人が自分の健康状態をモニターし、十分な情報を得た上でライフスタイルを変えることを可能にします。人口の高齢化と慢性疾患の増加により、OTC検査は定期的な健康モニタリングのための実用的なソリューションを提供し、早期発見と介入をサポートします。このアクセシビリティは、個人の健康結果を改善するだけでなく、日常的なモニタリングに必要なリソースが少なくて済むため、ヘルスケア施設の負担も軽減します。

さらに、OTC検査は、健康意識の高まりに呼応して、より多くの人々が自分の健康を管理する方法を求めていることから、支持を集めています。家族計画を立てているカップルのための不妊検査から、家系や素因を理解するための遺伝子検査キットまで、OTC検査は個別化された予防ヘルスケアの需要に応えています。検査技術の急速な進歩に伴い、信頼性が高く使いやすいOTC検査の種類も増え、多様なニーズに応えるとともに、個人が自分の健康について常に情報を得ることができるようになっています。OTC検査は、診断検査を一般の人々が利用できるようにすることで、個人とタイムリーなヘルスケアとのギャップを埋め、早期介入と積極的な健康管理を可能にします。

技術の進歩はOTC検査市場をどのように強化しているか？

技術の進歩はOTC検査市場の成長と進化に役立っており、検査をより正確に、手頃な価格で、使いやすくしています。生化学的検査と分子生物学的検査における技術革新は、OTC検査の感度と特異度を大幅に改善し、ラボベースの検査に匹敵する信頼性の高い結果をユーザーに提供しています。例えば、ラテラルフローやイムノアッセイ技術の進歩により、妊娠、感染症、薬物使用などの迅速検査が強化されました。これらの検査は現在、数分以内に結果が出るようになり、個人に迅速で便利な健康洞察を提供しています。Bluetooth対応の血糖測定器やスマートフォンのアプリなど、デジタル技術の統合により、ユーザーは自分の健康データを追跡、保存、分析できるようになり、十分な情報に基づいた意思決定や、必要に応じてヘルスケアプロバイダーと結果を共有するのに役立っています。

自宅での遺伝子検査も、技術の進歩の恩恵を受けている分野のひとつで、唾液サンプルからDNAを分析できるようになった。かつては高価で、専門の検査機関でしか入手できなかったDNA検査キットも、現在ではOTCチャネルで入手できるようになり、利用者は自分の家系、健康リスク、遺伝的素因についての洞察を得ることができます。これらの検査キットは、複雑な遺伝子データを解釈するために、高度なゲノム解析アルゴリズムと検査室での処理を使用し、消費者が利用しやすい形式で表示します。パーソナライズされた健康情報に対する人々の関心が高まるにつれ、OTC遺伝子検査は、ライフスタイルの選択や予防医療の指針となる遺伝的健康リスクを理解する簡単な方法を提供しています。個別化ヘルスケアの台頭がこうした検査への需要を煽り、OTC検査技術のさらなる革新を支えています。

遠隔医療とデジタルヘルスプラットフォームも、家庭での検査とヘルスケアプロバイダーをつなぐエコシステムを構築することで、OTC検査市場の成長を後押ししています。デジタルヘルスアプリの多くはOTC検査機器と互換性があり、ユーザーはヘルスケア専門家に遠隔で相談したり、検査結果に基づいた指導を受けたりすることができます。このようにOTC検査と遠隔医療が統合されることで、ユーザーは自宅で検査し、オンラインで医師に相談するというシームレスな体験を、すべて短時間で得ることができます。例えば、COVID-19在宅検査では、自宅にいながらにして検査結果を受け取ることができるため、被ばくを減らし、必要に応じてタイムリーな医療アドバイスを受けることができます。遠隔医療の導入が拡大するにつれ、在宅検査とバーチャル・ケアの相乗効果により、OTC検査の関連性が強まり、アクセスのしやすさと利便性を優先した総合的なヘルスケア体験が実現します。

消費者とヘルスケア・プロバイダーにとってのOTC検査の利点とは？

OTC検査は消費者と医療提供者の双方に大きなメリットをもたらし、ヘルスケアの利用しやすさと効率性を高める貴重なツールとなります。消費者にとってのOTC検査の主な利点は利便性です。自宅で検査ができるため、OTC検査では、従来のラボ検査に伴うスケジュールや移動、待ち時間が不要になります。この利便性は、移動に支障がある人、地方に住んでいる人、多忙なスケジュールでヘルスケア施設を訪れるのが困難な人にとって、特に有益です。妊娠検査、血糖測定器、迅速抗原検査などのOTC検査は、利用者にすぐに結果を提供し、安心感を与えます。検査機関への受診を減らすことで、OTC検査は消費者が自分の健康を管理し、いつでも健康状態をモニターできるようにし、積極的な健康管理をサポートします。

慢性疾患のある人にとって、OTC検査は継続的な健康モニタリングという重要な利点を提供します。定期的な血糖値、コレステロール値、血圧の在宅検査は、合併症を予防し、タイムリーな医療介入を可能にすることで、より効果的に病状を管理することを可能にします。この継続的なモニタリング機能により、頻繁に診療所を受診することなく便利に経過を追跡できるため、患者のコンプライアンスが向上します。OTC検査はまた、高コレステロールや異常なグルコース値のような状態の早期発見を促進することにより、健康結果を向上させる。例えば、家庭でできる大腸がんスクリーニング検査は早期発見を可能にし、早期に治療を開始することで生存率を大幅に向上させる。このように、OTC検査は予防医療において重要な役割を果たしており、個人が自分の健康について十分な情報を得た上で決断できるようサポートしています。

ヘルスケア提供者にとっても、OTC検査は医療施設の需要を軽減し、提供者が重要な症例に集中できるようになるという利点があります。患者が自分の健康状態を独自にモニターできるようにすることで、OTC検査は定期的な検査室訪問の回数を減らし、より集中的な治療を必要とする患者のためにリソースを確保することができます。これは、ヘルスケア・サービスに対する需要の高まりに対応し、ヘルスケア・システムのボトルネックを最小限に抑える上で特に有益です。さらに、OTC検査で収集したデータをヘルスケア・プロバイダーと共有することで、慢性疾患を持つ患者の遠隔モニタリングが可能になります。治療者はこのデータを使って患者の経過を追跡し、治療計画を調整し、問題が生じた場合には迅速に介入することができます。OTC検査は効率的な患者モニタリングを促進することで、転帰を向上させ、ヘルスケア・インフラへの負担を軽減するヘルスケアへの協調的アプローチをサポートします。

何がOTC検査市場の成長を促進しているのか？

OTC検査市場の成長を後押ししているのは、健康意識の高まり、利用しやすいヘルスケアソリューションへのニーズ、検査技術の進歩、慢性疾患の有病率の増加といった要因です。健康意識が高まり続ける中、自宅で健康状態をモニターできるツールを求める人が増え、OTC検査への需要が高まっています。今日の消費者は健康管理に積極的であり、OTC検査は高血圧、コレステロール、グルコース値などの状態を、頻繁に医師の診察を受けることなくチェックできる便利な方法を提供しています。このような自己管理アプローチは、個人が定期的に健康状態をモニターして潜在的な問題を早期に発見し対処するという、予防ヘルスケアの増加傾向に合致しています。

高齢化社会の到来と限られた資源の管理という課題に世界中のヘルスケア・システムが直面しているため、利用しやすいヘルスケア・ソリューションの必要性も、OTC検査市場の成長に大きく寄与しています。OTC検査は、個人が自宅で定期的な検査を受けられるようにすることで費用対効果の高いソリューションを提供し、ヘルスケア施設の負担を軽減し、より多くの人々が検査にアクセスできるようにします。ヘルスケアへのアクセスが制限されている地方や十分なサービスを受けていない地域では、OTC検査は、医療機関に出向くことなく必要不可欠な診断機能を提供することで、ギャップを埋める。医療費が上昇を続ける中、OTC検査は、特に医療インフラが限られている地域において、医療への幅広いアクセスをサポートする手頃な代替手段を提供します。

検査精度と使いやすさにおける技術の進歩も、OTC検査の採用を加速させています。バイオテクノロジーにおける技術革新は、OTC検査の信頼性と特異性を向上させ、高精度でラボベースの検査に匹敵するものにしました。例えば、迅速診断検査の進歩により、COVID-19やインフルエンザなどの感染症を自宅で検出することが可能になり、利用者は自己隔離や医療ケアの判断材料となる情報をタイムリーに得られるようになった。さらに、遠隔医療の台頭により、OTC検査がヘルスケアにさらに統合されました。遠隔診察やデジタル・ヘルス・プラットフォームにより、患者は自宅での検査結果に基づいて医療アドバイスを受けることができます。このOTC検査と遠隔医療のシームレスな統合は、アクセスしやすく効率的なヘルスケアソリューションを求める患者にとって特に魅力的です。

最後に、糖尿病、心血管疾患、高血圧などの慢性疾患の有病率の増加が、定期的なモニタリングを可能にするOTC検査製品への需要を促進しています。慢性疾患は頻繁な健康チェックを必要とするため、OTC検査は患者が一貫して自分の状態をモニターできる便利で効果的なソリューションを提供します。血糖値モニター、コレステロール検査、血圧計は、これらの慢性疾患を管理する人々が一般的に使用しており、必要に応じて治療計画を調整することを可能にしています。慢性疾患が依然として公衆衛生上の重要な問題であり、OTC検査が患者に積極的な健康管理の手段を提供することから、この動向は今後も続くと思われます。健康意識の高まり、利用しやすいヘルスケアの必要性、技術の進歩、慢性疾患の蔓延といったこれらの要因が相まって、OTC検査市場は大きく成長し、現代ヘルスケアと予防医学の要となっています。

セグメント

検査タイプ（グルコースモニタリング検査、妊娠・不妊検査、感染症検査、凝固モニタリング検査、尿検査、コレステロール検査、乱用薬物検査、その他の検査タイプ）、技術（ラテラルフローアッセイ、イムノアッセイ、ディップスティック）

調査対象企業の例（注目の合計33社）

  • Abbott Laboratories
  • AccuBioTech
  • ACON Laboratories
  • bioLytical Laboratories
  • i-Health Lab
  • LabStyle Innovations
  • NOWDiagnostics Company
  • OraSure Technologies
  • Roche Diagnostics
  • SD Biosensor
  • Sinocare

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP22445

Global Over The Counter (OTC) Testing Market to Reach US$43.6 Billion by 2030

The global market for Over The Counter (OTC) Testing estimated at US$23.3 Billion in the year 2023, is expected to reach US$43.6 Billion by 2030, growing at a CAGR of 9.3% over the analysis period 2023-2030. Glucose Monitoring Tests, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$11.7 Billion by the end of the analysis period. Growth in the Pregnancy & Fertility Tests segment is estimated at 9.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.3 Billion While China is Forecast to Grow at 8.8% CAGR

The Over The Counter (OTC) Testing market in the U.S. is estimated at US$6.3 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$6.8 Billion by the year 2030 trailing a CAGR of 8.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.8% and 7.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.6% CAGR.

Global Over-the-Counter (OTC) Testing Market - Key Trends & Drivers Summarized

Why Is Over-the-Counter Testing Essential for Accessible Healthcare?

Over-the-counter (OTC) testing has revolutionized healthcare by providing individuals with direct access to health tests that can be conducted privately and conveniently at home. OTC tests enable users to monitor a range of health indicators, from blood glucose and cholesterol levels to pregnancy, fertility, and infectious diseases, without requiring a doctor’s visit or prescription. As healthcare shifts toward more patient-centered and accessible care, OTC testing has become an essential tool for individuals seeking to manage their health proactively. By allowing people to test at their convenience, OTC tests eliminate barriers associated with traditional lab-based testing, such as time, cost, and accessibility issues, making healthcare more inclusive.

OTC testing has been particularly impactful for managing chronic conditions like diabetes, where continuous monitoring is crucial for effective care. Blood glucose meters, one of the most widely used OTC tests, empower diabetic patients to track their sugar levels daily, aiding in medication management and lifestyle adjustments. Similarly, at-home cholesterol tests allow individuals at risk of cardiovascular disease to monitor their health and make informed lifestyle changes. With an aging population and increasing rates of chronic illnesses, OTC testing provides a practical solution for regular health monitoring, supporting early detection and intervention. This accessibility not only improves individual health outcomes but also reduces the burden on healthcare facilities, as fewer resources are required for routine monitoring.

Additionally, OTC testing has gained traction in response to rising health awareness, as more people seek ways to take control of their wellness. From fertility tests for couples planning a family to genetic testing kits for understanding ancestry and predispositions, OTC testing meets the demand for personalized, preventive healthcare. With rapid advances in testing technology, a growing range of reliable, user-friendly OTC tests is now available, catering to diverse needs and empowering individuals to stay informed about their health. By making diagnostic testing accessible to the general public, OTC testing bridges the gap between individuals and timely healthcare, enabling early interventions and proactive health management.

How Are Technological Advancements Enhancing the OTC Testing Market?

Technological advancements have been instrumental in the growth and evolution of the OTC testing market, making tests more accurate, affordable, and user-friendly. Innovations in biochemical and molecular testing have significantly improved the sensitivity and specificity of OTC tests, providing users with reliable results that are comparable to lab-based testing. For example, advancements in lateral flow and immunoassay technologies have enhanced rapid testing for conditions like pregnancy, infectious diseases, and drug use. These tests now produce results within minutes, offering individuals fast, convenient health insights. Digital technology integration, such as Bluetooth-enabled blood glucose meters and smartphone apps, allows users to track, store, and analyze their health data, helping them make informed decisions and share results with healthcare providers as needed.

At-home genetic testing is another area that has benefited from technological advancements, making it possible to analyze DNA from a simple saliva sample. DNA testing kits, which were once expensive and only available through specialized labs, are now accessible through OTC channels and provide users with insights into their ancestry, health risks, and genetic predispositions. These kits use advanced genomic analysis algorithms and lab processing to interpret complex genetic data, presenting it in an accessible format for consumers. As people become more interested in personalized health information, OTC genetic testing offers an easy way to understand genetic health risks, which can guide lifestyle choices and preventive care. The rise of personalized healthcare has fueled demand for these tests, supporting further innovation in OTC testing technology.

Telemedicine and digital health platforms have also driven growth in the OTC testing market by creating an ecosystem that connects at-home testing with healthcare providers. Digital health apps, many of which are compatible with OTC testing devices, allow users to consult healthcare professionals remotely and receive guidance based on their test results. This integration of OTC testing with telemedicine provides a seamless experience, where users can test at home and consult a doctor online, all within a short timeframe. For example, COVID-19 home tests allow individuals to receive test results without leaving their home, reducing exposure and facilitating timely medical advice if needed. As telemedicine adoption expands, the synergy between at-home testing and virtual care strengthens the relevance of OTC tests, creating a holistic healthcare experience that prioritizes accessibility and convenience.

What Are the Benefits of OTC Testing for Consumers and Healthcare Providers?

OTC testing provides substantial benefits for both consumers and healthcare providers, making it a valuable tool in enhancing healthcare accessibility and efficiency. For consumers, the main advantage of OTC testing is convenience. By enabling people to test at home, OTC testing eliminates the need for scheduling, travel, and waiting times associated with traditional lab tests. This convenience is especially beneficial for individuals with mobility issues, those living in rural areas, or people with busy schedules who find it challenging to visit a healthcare facility. OTC tests, such as pregnancy tests, blood glucose meters, and rapid antigen tests, offer users immediate results and peace of mind. By reducing the dependency on lab visits, OTC testing empowers consumers to take control of their health and monitor their well-being at any time, supporting proactive health management.

For individuals with chronic conditions, OTC testing offers the critical benefit of continuous health monitoring. Regular at-home testing for blood glucose, cholesterol, or blood pressure enables individuals to manage their conditions more effectively, preventing complications and allowing for timely medical interventions. This continuous monitoring capability improves patient compliance, as users can conveniently track their progress without frequent clinic visits. OTC tests also enhance health outcomes by promoting early detection of conditions like high cholesterol or abnormal glucose levels, allowing individuals to make lifestyle changes or seek medical advice before conditions worsen. For example, at-home colon cancer screening tests allow for early detection, significantly improving survival rates when treatment begins early. OTC testing thus plays a crucial role in preventive care, supporting individuals in making informed decisions about their health.

Healthcare providers also benefit from OTC testing, as it helps alleviate the demand on healthcare facilities and enables providers to focus on critical cases. By empowering patients to monitor their health independently, OTC testing reduces the number of routine lab visits, freeing up resources for patients who require more intensive care. This is particularly beneficial in managing the rising demand for healthcare services and minimizing bottlenecks in the healthcare system. Additionally, data collected from OTC testing can be shared with healthcare providers, allowing for remote monitoring of patients with chronic conditions. Providers can use this data to track patient progress, make adjustments to treatment plans, and intervene promptly if issues arise. By facilitating efficient patient monitoring, OTC testing supports a collaborative approach to healthcare that enhances outcomes and reduces the burden on healthcare infrastructure.

What Is Fueling the Growth in the OTC Testing Market?

The growth in the OTC testing market is driven by factors such as rising health awareness, the need for accessible healthcare solutions, advancements in testing technology, and the increasing prevalence of chronic conditions. As health awareness continues to rise, more people are seeking tools that allow them to monitor their health from home, leading to a greater demand for OTC tests. Consumers today are more proactive in managing their health, and OTC testing offers a convenient way to check for conditions like high blood pressure, cholesterol, and glucose levels without the need for frequent doctor visits. This self-management approach aligns with the growing trend of preventive healthcare, where individuals monitor their health regularly to detect and address potential issues early.

The need for accessible healthcare solutions has also contributed significantly to the growth of the OTC testing market, as healthcare systems worldwide face challenges in meeting the demands of an aging population and managing limited resources. OTC testing provides a cost-effective solution by enabling individuals to take routine tests at home, reducing the burden on healthcare facilities and making testing accessible to a wider population. In rural or underserved areas where healthcare access is limited, OTC testing bridges the gap by providing essential diagnostic capabilities without requiring travel to a medical facility. As healthcare costs continue to rise, OTC testing offers an affordable alternative that supports broader access to healthcare, especially in regions with limited medical infrastructure.

Technological advancements in testing accuracy and ease of use have also accelerated the adoption of OTC testing. Innovations in biotechnology have improved the reliability and specificity of OTC tests, making them highly accurate and comparable to lab-based tests. For instance, advancements in rapid diagnostic tests have made it possible to detect infectious diseases like COVID-19 and influenza at home, providing users with timely information that can guide decisions on self-isolation and medical care. Additionally, the rise of telehealth has further integrated OTC testing into healthcare, as remote consultations and digital health platforms allow patients to receive medical advice based on their at-home test results. This seamless integration of OTC testing and telemedicine is especially appealing to patients seeking accessible and efficient healthcare solutions.

Finally, the increasing prevalence of chronic conditions, such as diabetes, cardiovascular disease, and high blood pressure, has fueled demand for OTC testing products that allow for regular monitoring. As chronic diseases require frequent health checks, OTC testing offers a convenient, effective solution for patients to monitor their condition consistently. Blood glucose monitors, cholesterol tests, and blood pressure cuffs are commonly used by individuals managing these chronic conditions, enabling them to adjust their treatment plans as needed. This trend is likely to continue as chronic conditions remain a significant public health issue, with OTC testing providing patients with the tools to manage their health proactively. Together, these factors—rising health awareness, the need for accessible healthcare, technological advancements, and the prevalence of chronic conditions—are driving substantial growth in the OTC testing market, making it a cornerstone of modern healthcare and preventive medicine.

SCOPE OF STUDY:

The report analyzes the Over The Counter (OTC) Testing market in terms of US$ Million by the following Technology; Test Type, and Geographic Regions/Countries:

Segments:

Test Type (Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests, Other Test Types); Technology (Lateral Flow Assays, Immunoassays, Dipsticks)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 33 Featured) -

  • Abbott Laboratories
  • AccuBioTech
  • ACON Laboratories
  • bioLytical Laboratories
  • i-Health Lab
  • LabStyle Innovations
  • NOWDiagnostics Company
  • OraSure Technologies
  • Roche Diagnostics
  • SD Biosensor
  • Sinocare

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Over The Counter (OTC) Testing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Home-Based Health Monitoring Drives OTC Testing Market
    • Increasing Awareness About Preventive Healthcare Sets the Stage for OTC Testing Adoption
    • Rising Adoption of Self-Testing Kits for Chronic Disease Management
    • Increasing Use of OTC Testing in Monitoring Infectious Diseases Propels Demand
    • Demand for Rapid and Accurate Results Spurs OTC Testing Solutions
    • OTC Testing as a Key Solution for Reducing Healthcare Costs
    • Use in Detecting Lifestyle Disorders Expands OTC Testing Adoption
    • Rising Demand for Genetic Testing Kits Sets the Stage for Market Growth
    • Increasing Use of OTC Testing in Monitoring Diabetes and Heart Conditions
    • Increasing Focus on Female Health Solutions Expands OTC Testing Opportunities
    • OTC Testing for Allergies and Food Intolerances Generates Demand
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Over The Counter (OTC) Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Over The Counter (OTC) Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Glucose Monitoring Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Glucose Monitoring Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Glucose Monitoring Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Pregnancy & Fertility Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Pregnancy & Fertility Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Pregnancy & Fertility Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Infectious Disease Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Infectious Disease Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Infectious Disease Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Coagulation Monitoring Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Coagulation Monitoring Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Coagulation Monitoring Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Urinalysis Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Urinalysis Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Urinalysis Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Cholesterol Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Cholesterol Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Cholesterol Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Drugs-of-Abuse Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Drugs-of-Abuse Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Drugs-of-Abuse Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Other Test Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 30: World 16-Year Perspective for Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Dipsticks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Dipsticks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 33: World 16-Year Perspective for Dipsticks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Lateral Flow Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Lateral Flow Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 36: World 16-Year Perspective for Lateral Flow Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 37: World Over The Counter (OTC) Testing Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2024 & 2030
  • JAPAN
    • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2024 & 2030
  • CHINA
    • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2024 & 2030
  • EUROPE
    • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Over The Counter (OTC) Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Over The Counter (OTC) Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2024 & 2030
  • FRANCE
    • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 71: France Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: France 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: France 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2024 & 2030
  • GERMANY
    • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Germany 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Italy 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 89: UK Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: UK 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 92: UK Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: UK 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 107: Rest of World Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of World Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of World 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 110: Rest of World Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Rest of World Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Rest of World 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2024 & 2030

IV. COMPETITION